Arch Therapeutics (OTCMKTS:ARTH) Stock Crosses Below Fifty Day Moving Average of $2.44

Arch Therapeutics, Inc. (OTCMKTS:ARTHGet Free Report)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $2.44 and traded as low as $1.70. Arch Therapeutics shares last traded at $1.85, with a volume of 5,083 shares trading hands.

Arch Therapeutics Trading Up 2.8 %

The company has a fifty day moving average price of $2.44 and a two-hundred day moving average price of $3.30.

Arch Therapeutics (OTCMKTS:ARTHGet Free Report) last released its quarterly earnings data on Tuesday, February 20th. The biotechnology company reported ($0.57) earnings per share for the quarter. The firm had revenue of $0.05 million during the quarter. On average, analysts forecast that Arch Therapeutics, Inc. will post 24.77 earnings per share for the current fiscal year.

Arch Therapeutics Company Profile

(Get Free Report)

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.

Featured Stories

Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.